Thrombospondin receptor (CD36) expression of human keratinocytes during wound healing in a SCID mouse/human skin repair model

J Dermatol. 1996 May;23(5):305-9. doi: 10.1111/j.1346-8138.1996.tb04020.x.

Abstract

Using a human skin/severe combined immunodeficient (SCID) chimeric mouse model, we examined the keratinocyte expression of the thrombospondin receptor (CD36) and its ligand thrombospondin-1 (TSP1) in acute uninflamed wounds. Positive suprabasal keratinocyte expression of CD36 was observed as early as 30 minutes after wounding in the adjacent, intact epidermis; it disappeared 4 days later. Keratinocytes of the freshly re-epithelised wounds and those of the surrounding epidermis remained TSP1-negative throughout the whole observation period of 7 days. Our results indicate that CD36-positive keratinocytes, probably in connection with activated, TSP1-positive thrombocytes, may play an important role in the early phase of wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD36 Antigens / metabolism*
  • Humans
  • Immunohistochemistry
  • Keratinocytes / immunology*
  • Keratinocytes / metabolism
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, SCID
  • Models, Biological
  • Skin / injuries*
  • Skin / metabolism
  • Thrombospondins
  • Wound Healing

Substances

  • CD36 Antigens
  • Membrane Glycoproteins
  • Thrombospondins